Highlights Bristol-Myers Squibb Company

Equities

BMY

US1101221083

Market Closed - Nyse Other stock markets 04:00:02 2024-04-26 pm EDT			5-day change	1st Jan Change
44.85 ^USD	+0.34%		-8.34%	-12.59%

Apr. 26	S&P 500 Q1 earnings estimated growth improves; stocks up for week	RE
Apr. 26	Leerink Partners Cuts Price Target on Bristol-Myers Squibb to $47 From $51	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

S&P 500 Q1 earnings estimated growth improves; stocks up for week	Apr. 26	RE
Bristol-Myers Squibb Says European Regulator Recommends Approval of Bladder Cancer Combination Therapy	Apr. 26	MT
Health Care Drops Amid Mixed Earnings -- Health Care Roundup	Apr. 25	DJ
Sector Update: Health Care Stocks Decline Late Afternoon	Apr. 25	MT
Sector Update: Health Care Stocks Drop in Afternoon Trading	Apr. 25	MT
Sector Update: Health Care	Apr. 25	MT
Bristol-Myers Squibb Swings to Q1 Non-GAAP Loss, Revenue Rises; Provides 2024 Guidance -- Shares Fall	Apr. 25	MT
Global markets live: Ford, Dow, American Airlines, Comcast, Apple, IBM, Cisco...	Apr. 25
Stocks in motion: Large caps struggle	Apr. 25
Trending : Bristol Myers Squibb Cuts '24 EPS Outlook, Plans Job Cuts in Cost Saving Efforts	Apr. 25	DJ
The specter of stagflation rears its ugly head again	Apr. 25
Bristol-Myers Squibb Swings to Q1 Non-GAAP Loss, Revenue Rises; Provides 2024 Guidance	Apr. 25	MT
Bristol Myers: heavy quarterly loss on charges	Apr. 25	CF
Bristol-Myers Cuts '24 EPS View, Posts Narrower-Than-Seen 1Q Loss	Apr. 25	DJ
(BMY) BRISTOL MYERS SQUIBB Sees Fiscal Year 2024 EPS Range $0.40 - $0.70	Apr. 25	MT
Earnings Flash (BMY) BRISTOL MYERS SQUIBB Posts Q1 Revenue $11.87B, vs. Street Est of $11.45B	Apr. 25	MT
Bristol-Myers Squibb Company Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
Bristol Myers posts quarterly loss, revenue rises 5%	Apr. 25	RE
Futures falter as Meta Platforms weighs on megacaps	Apr. 25	RE
Novartis Lifts 2024 Guidance as First-quarter Earnings Grow on Strong Blockbuster Drug Demand	Apr. 23	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Christopher Boerner, CEO of Bristol-Myers: A pipeline of 16 treatments, with a focus on neuroscience and oncology

January 09, 2024 at 01:06 pm EST